Germline variants were the dominant source of effect on innate immunity, epithelial–mesenchymal transition, and extracellular matrix pathways whereas sMs were the dominant contributor to alterations in cancer driver genes, cell cycle and apoptosis, WNT and TGFbeta pathways. Here, TGFB1 is linked to cancer.